# Co-primary endpoint. Duration of effect was defined as the complete return of muscle activity and was assessed by patients following treatment of glabellar lines (N=85).
Reference 1. Schlessinger J et al. Dermatol Surg, 2021;47(4): 504-5092. 2. Kassir R et al. Dermatol Ther. 2013;3(2):179–189. 3. Monheit GD, Pickett A. Aesthet Surg J.2017:37:S4-S11 4. Summary of Safefy and Effectivenessdata. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/125274Orig1s118lbl.pdf 5. Field M et al. Toxins, 2018:10:535. 6. Frevert J. et al Clinical. Cosmetic andInvestigational Dermatology 2018:11 327-331 7. Dysport Summary of ProductCharacteristics. 8. Data on file MA-39680.; Data on fileMA-40221.; Data on file MA-39613. 9. Data on file MA-52573. 10. Dysport US PI.